The purpose of this study is to see whether using ketamine to increase glutamate in the
prefrontal cortex can reduce Multiple Sclerosis (MS) related fatigue. We propose a
prospective, crossover, randomized, placebo-controlled study to assess the efficacy and
safety of low, single dose Ketamine, to assess its efficacy and safety in patients with
MS-related fatigue.